Floatz logo

Sra-333

Delirium, Dementia, Amnestic, Cognitive Disorders

New York State Psychiatric InstitutePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Delirium, Dementia, Amnestic, Cognitive Disorders cohort.

Asset / SponsorPhaseRating
Intranasal Auto-M2-Bfs
Russian Academy of Medical Sciences
Phase 1/2CCC
L-Leucine
Washington University School of Medicine
D
Neurostem®-Ad
Duk Lyul Na
D

Same molecule, other indications

Sra-333 is also rated in:

Dementia With Lewy Bodies (DLB)Dormant
BBB
Indicative ·
76 / 100
View asset →
DementiaDormant
BBB
Indicative ·
74 / 100
View asset →
Alzheimer's DiseaseDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →